Werewolf Therapeutics Inc HOWL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:09 PM EST
1.66quote price arrow up+0.12 (+8.17%)
Volume
122,332
52 week range
1.39 - 15.75
Loading...
  • Open1.56
  • Day High1.67
  • Day Low1.54
  • Prev Close1.53
  • 52 Week High15.75
  • 52 Week High Date12/08/21
  • 52 Week Low1.39
  • 52 Week Low Date12/07/22

Key Stats

  • Market Cap50.882M
  • Shares Out30.74M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-85.98

KEY STATS

  • Open1.56
  • Day High1.67
  • Day Low1.54
  • Prev Close1.53
  • 52 Week High15.75
  • 52 Week High Date12/08/21
  • 52 Week Low1.39
  • 52 Week Low Date12/07/22
  • Market Cap50.882M
  • Shares Out30.74M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-85.98

RATIOS/PROFITABILITY

  • EPS (TTM)-2.14
  • P/E (TTM)-0.77
  • Fwd P/E (NTM)-0.77
  • EBITDA (TTM)-60.026M
  • ROE (TTM)-39.80%
  • Revenue (TTM)9.118M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-655.29%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/24/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Werewolf Therapeutics Inc

 

Profile

MORE
Werewolf Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of cancer treatments. The Company is developing immuno-stimulatory therapeutics designed to act selectively within the tumor microenvironment to enhance the body’s immune response to cancer. The Company’s product candidates include WTX-124, WTX-330 and WTX-613. The Company’s advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated...
Luke Evnin Ph.D.
Independent Chairman of the Board
Daniel Hicklin Ph.D.
President, Chief Executive Officer, Director
Reid Leonard Ph.D.
Chief Operating Officer
Timothy Trost CPA
Chief Financial Officer, Treasurer
Chulani Karunatilake Ph.D.
Chief Technology Officer
Address
200 Talcott Avenue, 2Nd Floor
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
ISR
Isoray Inc
0.3272-0.0166-4.8284%
HOOK
HOOKIPA Pharma Inc
0.84-0.035-4.00%
OCX
OncoCyte Corp
0.4359-0.0285-6.137%
ARAV
Aravive Inc
1.50+0.04+3.08%
SLDB
Solid Biosciences Inc
6.74+0.14+2.12%